Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
Condition:   InfluenzaInterventions:   Biological: Inactivated H1N1 vaccine;   Biological: Inactivated H1N1 vaccineSponsor:   University of RochesterCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2009 Category: Research Source Type: clinical trials

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults
Condition:   InfluenzaIntervention:   Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274ASponsor:   GlaxoSmithKlineWithdrawn - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2009 Category: Research Source Type: clinical trials

Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children
Condition:   InfluenzaIntervention:   Biological: adjuvanted ArepanrixSponsors:   University of British Columbia;   Canadian Institutes of Health Research  (CIHR);   PHAC/CIHR Influenza Research NetworkCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2009 Category: Research Source Type: clinical trials

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults
Condition:   H1N1/2009 InfluenzaInterventions:   Biological: Arepanrix;   Biological: ArepanrixSponsors:   David Scheifele;   Canadian Institutes of Health Research  (CIHR);   PHAC/CIHR Influenza Research NetworkCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2009 Category: Research Source Type: clinical trials

Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children
Condition:   InfluenzaIntervention:   Biological: adjuvanted ArepanrixSponsors:   University of British Columbia;   Canadian Institutes of Health Research  (CIHR);   PHAC/CIHR Influenza Research NetworkCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2009 Category: Research Source Type: clinical trials

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults
Condition:   H1N1/2009 InfluenzaInterventions:   Biological: Arepanrix;   Biological: ArepanrixSponsors:   David Scheifele;   Canadian Institutes of Health Research  (CIHR);   PHAC/CIHR Influenza Research NetworkCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2009 Category: Research Source Type: clinical trials

Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children
Condition:   InfluenzaIntervention:   Biological: adjuvanted ArepanrixSponsors:   University of British Columbia;   Canadian Institutes of Health Research  (CIHR);   PHAC/CIHR Influenza Research NetworkCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2009 Category: Research Source Type: clinical trials

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons
Conditions:   Influenza;   HIV InfectionsIntervention:   Sponsors:   Uniformed Services University of the Health Sciences;   Infectious Diseases Clinical Research Program;   National Institute of Allergy and Infectious Diseases (NIAID)Active, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2009 Category: Research Source Type: clinical trials